sAn rAffAele biomediCAl PArk foundAtion MARKET SECTOR
Biotechnolgies
COMPANY DESCRIPTION
The non profit foundation Fondazione Parco Biomedico San Raffaele (SPR) strives to establish communication between science and technology of uncompromised quality, and the development of innovation with applicative, medical and economical significance.
PROJECT PROPOSAL
A scientific research institute has been established at SPR, dedicated to tissue engineering and stem cell biology (IBCIT) with up to date facilities for cell biology and gene therapy translational studies. IBCIT research units are: ■ Diabetology and molecular endocrinology ■ Hematopoiesis and leukemogenesis ■ Immunology ■ Molecular cardiology ■ Molecular medicine ■ Skeletal diseases ■ Stem cells ■ Stem cells and muscolar distrophies ■ Tumor epigenetics ■ Viral vectors and gene therapy
INNOVATION AND ADVANTAGES
The goal of SPR is to develop, support and promote cutting-edge public and private basic and translational research in the field of regenerative medicine, stem cell research, biotechnology, molecular medicine and gene therapy. To support modern, high level biomedical research, SPR fondation has created conventions with universities in the Roman area, links with several private investors, and has set up in the scientific park several key facility cores available to researchers on site and as services to researchers out of SPR. Facilities include: ■ Laboratory animal resource centre ■ Flow cytometry core ■ Microscopy core ■ Stem cell culture core ■ Viral culture core and P2 suite
Web Site: www.scienceparkrome.eu Contact: Valentina Grassi Telephone: + 39 06 80319083 Fax: + 39 06 80319074 Email: valentina.grassi@spr-r.it Address: Via di Castel Romano, 100 Rome Italy
MARKET CHARACTERISTICS & OPPORTUNITIES
Advanced generations of drugs developed through biotechnology continue to enter the marketplace. The results promise to be spectacular for patients, as a technology tipping point of medical care is nearing, where drugs that target specific genes and proteins will become widespread. The pharmaceutical industry is focused on finding new products that will replace expired blockbuster revenues and upcoming pharmacogenomics tools open new opportunities.
STATE OF DEVELOPMENT
SPR supports the development of projects in the field of regenerative medicine, stem cell research and tissue engineering with particular focus on the area developed by IBCIT researchers .
INTELLECTUAL PROPERTY RIGHTS
Patents’ approval under way.
SOUGHT OPPORTUNITIES
New opportunities in biotech market and regenerative medicine market. To team up with venture capitals since SPR intends to generate spin-off. 61